Name
AS Bravo Healthcare
Registry code
12846147
VAT number
EE101872580
Type
AS - Joint Stock Company
Status
Registered
Foundation date
06.05.2015 (9)
Financial year
01.01-31.12
Capital
181 890.00 €
Activity
72111 - Research and experimental development on biotechnology
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Rakesh Pandey 10.12.1977 (46) | - | Board member | Direct ownership | Founder |
| Nishant Kumar 18.10.1983 (41) | - | - | - | Board member |
| Reena Singh 13.03.1978 (46) | - | - | - | Board member |
| Ivo Nagel 07.09.1977 (47) | - | - | - | Chairman of the board |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MTÜ Personalised Medicine Association 80561497 | - | - | - | Founder (without contribution) |
| 2019 21.09.2021 | 2020 26.10.2021 | 2021 22.03.2023 | |
|---|---|---|---|
| Total Revenue | 133 377 € | 166 345 € | 4 230 € |
| Net profit (loss) for the period | -29 744 € | 2 616 € | -58 434 € |
| Profit Margin | -22% | 2% | -1381% |
| Current Assets | 261 776 € | 260 761 € | 252 440 € |
| Fixed Assets | 52 635 € | 23 743 € | 4 298 € |
| Total Assets | 314 411 € | 284 504 € | 256 738 € |
| Current Liabilities | 14 515 € | 137 856 € | 177 524 € |
| Non Current Liabilities | 158 234 € | 2 370 € | 2 370 € |
| Total Liabilities | 172 749 € | 140 226 € | 179 894 € |
| Share Capital | 100 000 € | 100 000 € | 100 000 € |
| Equity | 141 662 € | 144 278 € | 76 844 € |
| Employees | 3 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 5 703.29 € | 980.73 € | 867.09 € | 1 |
| 2023 Q4 | 2 115.83 € | - | 867.09 € | 1 |
| 2023 Q3 | - | 812.19 € | 867.09 € | 1 |
| 2023 Q2 | - | 812.19 € | 867.09 € | 1 |
| 2023 Q1 | - | 842.99 € | 897.89 € | 1 |
| 2022 Q4 | 6 054.05 € | 1 099.37 € | 1 080.77 € | 1 |
| 2022 Q3 | - | 1 489.18 € | 1 323.33 € | 1 |
| 2022 Q2 | 500 € | 1 488.93 € | 1 323.33 € | 1 |
| 2022 Q1 | - | - | 1 361.81 € | 1 |
| 2021 Q4 | 3 567.65 € | 1 553.85 € | 1 363.75 € | 1 |
| 2021 Q3 | 12 440.18 € | 2 164.13 € | 1 743.73 € | 1 |
| 2021 Q2 | 328.21 € | 1 499.76 € | 933.81 € | 1 |
| 2021 Q1 | 537.09 € | - | 933.81 € | 1 |
| 2020 Q4 | 78.21 € | 1 499.76 € | 933.81 € | 1 |
| 2020 Q3 | 1 114.54 € | 2 018.24 € | 3 761.99 € | 1 |
| 2020 Q2 | 87 728.33 € | 4 693.7 € | 4 192.5 € | 3 |
| 2020 Q1 | 127 074.04 € | 1 294.31 € | 2 842.22 € | 3 |
